Advertisement

Drugs & Aging

, Volume 28, Issue 7, pp 575–581 | Cite as

Co-Morbidity and Potential Treatment Conflicts in Elderly Heart Failure Patients

A Retrospective, Cross-Sectional Study of Administrative Claims Data
  • Gillian E. CaugheyEmail author
  • Elizabeth E. Roughead
  • Sepehr Shakib
  • Agnes I. Vitry
  • Andrew L. Gilbert
Original Research Article

Abstract

Background: Co-morbidity of both cardiac and non-cardiac conditions is common in the elderly with heart failure (HF) and can be associated with adverse clinical outcomes.

Objectives: The aims of this study were to examine the prevalence of comorbidity and potential treatment conflicts that may result in adverse clinical outcomes in a large cohort of elderly HF patients.

Methods: We conducted a cross-sectional study using administrative claims data (1 April to 31 July 2007) from the Department of Veterans’ Affairs, Australia, on all veterans aged ≥65 years with HF. Co-morbidities were defined using the pharmaceutical based co-morbidity index Rx-Risk-V. Potential treatment conflicts for patients with HF and co-morbid diseases were identified from Australian clinical guidelines or reference compendia and their prevalence in the data were determined.

Results: A total of 6730 patients were included in the study, with a median of 6 co-morbid conditions (interquartile range [IQR] 4–7) and 11 (IQR 8–15) unique medicines. Almost the entire HF cohort (97.8%) were identified as having at least one co-morbid condition that may cause a potential treatment conflict, with 55% having three or more. The conditions identified as being of greatest concern, based on their prevalence and potential for treatment conflict, were chronic airways disease, depression, chronic pain/inflammatory disease, glaucoma, diabetes mellitus and diseases treatable with corticosteroids.

Conclusions: Potential treatment conflicts are common in the highly co-morbid population of elderly patients with HF, and may influence the therapeutic management of not only HF but all conditions present.

Keywords

Heart Failure Heart Failure Patient Adverse Clinical Outcome Prior Authorization Home Medicine Review 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This work was funded by the Australian Research Council/National Health and Medical Research Council of Australia from an Ageing Well Ageing Productively Program Grant and the work was independent of the funding source.

We thank the Australian Department of Veterans’ Affairs for providing the data used in this study. We also thank Professors Philip Ryan, Professor Adrian Esterman, Professor Mary Luszcz and Professor Robyn McDermott, the chief investigators who also collaborated with us on this project.

The authors declare they have no financial or any other kinds of personal conflicts associated with this manuscript.

References

  1. 1.
    Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet 2003; 362(9378): 147–58PubMedCrossRefGoogle Scholar
  2. 2.
    Najafi F, Dobson AJ, Jamrozik K. Recent changes in heart failure hospitalisations in Australia. Eur J Heart Fail 2007; 9(3): 228–33PubMedCrossRefGoogle Scholar
  3. 3.
    Krum H, Tonkin AM, Currie R, et al. Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) study. Med J Aust 2001; 174(9): 432–3Google Scholar
  4. 4.
    Ko DT, Alter DA, Austin PC, et al. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart Journal 2008; 155(2): 324–31CrossRefGoogle Scholar
  5. 5.
    Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics — 2010 update: a report from the American Heart Association. Circulation 2010; 121(7): 948–54PubMedCrossRefGoogle Scholar
  6. 6.
    Caughey GE, Ramsay EN, Vitry AI, et al. Comorbid chronic diseases, discordant impact on mortality in the elderly: a 14 year longitudinal population study. J Epidemiol Comm Health 2010; 64: 1036–42CrossRefGoogle Scholar
  7. 7.
    Weiss CO, Boyd CM, Yu Q, et al. Patterns of prevalent major chronic disease among older adults in the United States. JAMA 2007; 298(10): 1160–2PubMedGoogle Scholar
  8. 8.
    Brown AM, Cleland JGF. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J 1998; 19(7): 1063–9PubMedCrossRefGoogle Scholar
  9. 9.
    Rich MW. Heart failure in the oldest patients: the impact of comorbid conditions. Am J Geriatr Cardiol 2005; 14(3): 134–41PubMedCrossRefGoogle Scholar
  10. 10.
    Braunstein JB, Anderson GF, Gerstenblith G, et al. Non-cardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiology 2003; 42(7): 1226–33CrossRefGoogle Scholar
  11. 11.
    Dahlstrom U. Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 2005; 7(3): 309–16PubMedCrossRefGoogle Scholar
  12. 12.
    Krum H, Jelinek MV, Stewart S, et al., on behalf of the CHF Guidelines Core Writers. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust 2006; 185(10): 549–56PubMedGoogle Scholar
  13. 13.
    Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20(11): 817–32PubMedCrossRefGoogle Scholar
  14. 14.
    Milton JC, Hill-Smith I, Jackson SH. Prescribing for older people. BMJ 2008; 336(7644): 606–9PubMedCrossRefGoogle Scholar
  15. 15.
    Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts. Diab Res Clin Prac 2010; 87: 385–93CrossRefGoogle Scholar
  16. 16.
    Roughead EE, Barratt JD, Ramsay E, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalisation for heart failure patients in the practice setting: results of a cohort study. Circ Heart Fail 2009; 2(5): 424–8PubMedCrossRefGoogle Scholar
  17. 17.
    Australian Bureau of Statistics. Census of population and housing — Socio-Economic Indexes for Areas (SEIFA) 2001. Belconnen (ACT): Australian Bureau of Statistics, 2001Google Scholar
  18. 18.
    Caughey GE, Vitry AI, Gilbert AL, et al. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health 2008; 8(1): 221–33PubMedCrossRefGoogle Scholar
  19. 19.
    Cardiovascular Expert Group. Therapeutic guidelines: cardiovascular. Version 5. Melbourne (VIC): Therapeutic Guidelines Limited, 2008Google Scholar
  20. 20.
    Australian medicines handbook 2008. Adelaide (SA): Australian Medicines Handbook Pty. Ltd., 2009Google Scholar
  21. 21.
    Huerta C, Castellsague J, Varas-Lorenzo C, et al. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 2005; 45(3): 531–9PubMedCrossRefGoogle Scholar
  22. 22.
    Schäcke H, Döcke W-D, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharm Therapeut 2002; 96(1): 23–43CrossRefGoogle Scholar
  23. 23.
    Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004; 351(11): 1106–18PubMedCrossRefGoogle Scholar
  24. 24.
    Abramson MJ, Crockett AJ, Frith PA, et al. COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust 2006; 184(7): 342–5PubMedGoogle Scholar
  25. 25.
    Jiang W, Davidson JRT. Antidepressant therapy in patients with ischemic heart disease. Am Heart J 2005; 150(5): 871–81PubMedCrossRefGoogle Scholar
  26. 26.
    Goldberg I, Adena MA. Co-prescribing of topical and systemic beta-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice. Clin Experiment Ophthalmol 2007; 35(8): 700–5PubMedCrossRefGoogle Scholar
  27. 27.
    Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations after heart failure diagnosis: a community perspective. J Am Coll Cardiol 2009; 54(18): 1695–702PubMedCrossRefGoogle Scholar
  28. 28.
    Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 2006; 295(16): 1935–40PubMedCrossRefGoogle Scholar
  29. 29.
    Clark RA, Eckert KA, Stewart S, et al. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study. Med J Aust 2007; 186(9): 441–5PubMedGoogle Scholar
  30. 30.
    Thavapalachandran S, Leong DP, Stiles MK, et al. Evidencebased management of heart failure in clinical practice: a review of device-based therapy use. Int Med J 2009; 39(10): 669–75CrossRefGoogle Scholar
  31. 31.
    Rao A, Walsh J. Impact of specialist care in patients with newly diagnosed heart failure: a randomised controlled study. Int J Cardiol 2007; 115(2): 196–202PubMedCrossRefGoogle Scholar
  32. 32.
    Hauptman PJ, Rich MW, Heidenreich PA, et al. The heart failure clinic: a consensus statement of the Heart Failure Society of America. J Cardiac Fail 2008; 14(10): 801–15CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2011

Authors and Affiliations

  • Gillian E. Caughey
    • 1
    Email author
  • Elizabeth E. Roughead
    • 1
  • Sepehr Shakib
    • 2
  • Agnes I. Vitry
    • 1
  • Andrew L. Gilbert
    • 1
  1. 1.Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia
  2. 2.Department of Clinical PharmacologyRoyal Adelaide HospitalAdelaideAustralia

Personalised recommendations